Join now Sign in Submit
815,626,155
Searches
3,745,947
Submissions
663,478
Sites
7,692
Categories
300,360
Editors
279,951
Contributors

Glecaprevir and Pibrentasvir for HCV in Kidney Disease

A 12-week treatment of glecaprevir and pibrentasvir in stage 4 or 5 chronic kidney disease patients with hepatitis C (HCV) resulted in a high response rate.

  • Viesearch
    Moderated and indexed this listing ·
  • @emedeventseditor
    Submitted this listing ·

Editorial Actions

Feature Edit